Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2

CJ Hawkes, C Wasmeier, MR Christie, JC Hutton - Diabetes, 1996 - Am Diabetes Assoc
CJ Hawkes, C Wasmeier, MR Christie, JC Hutton
Diabetes, 1996Am Diabetes Assoc
Antibodies to islet cell proteins detected as 37,000 and 40,000 Mr tryptic fragments (37-and
40-kDa antigens) are strongly associated with progression to IDDM. The 40-kDa antigen has
recently been identified as the tyrosine phosphatase-like protein IA-2 (ICA512) whereas the
37-kDa antigen has been suggested to be a different protein that has structural similarity to
IA-2. A protein, phogrin, that has 80% amino acid sequence identity to IA-2 in the
cytoplasmic domain, has recently been cloned from an insulinoma cell cDNA library. In this …
Antibodies to islet cell proteins detected as 37,000 and 40,000 Mr tryptic fragments (37- and 40-kDa antigens) are strongly associated with progression to IDDM. The 40-kDa antigen has recently been identified as the tyrosine phosphatase-like protein IA-2 (ICA512) whereas the 37-kDa antigen has been suggested to be a different protein that has structural similarity to IA-2. A protein, phogrin, that has 80% amino acid sequence identity to IA-2 in the cytoplasmic domain, has recently been cloned from an insulinoma cell cDNA library. In this study, we have investigated possible relationships between the 37-kDa antigen and phogrin. Antibodies to phogrin were detected in sera from patients with IDDM, and these antibodies were strongly correlated with the presence of antibodies to the 37-kDa antigen. Trypsin treatment of immunoprecipitated phogrin generated a 37,000 Mr fragment. Recombinant phogrin was able to block autoantibody binding to the 37-kDa antigen but not to the 40-kDa antigen, and rabbit antibodies raised to different regions of phogrin depleted insulinoma cell extracts specifically of the 37-kDa antigen. These results demonstrate that the 37-kDa antigen in IDDM is indistinguishable from phogrin and show that two distinct tyrosine phosphatase-related proteins are major targets of the autoimmune response in the disease.
Am Diabetes Assoc